AR192734A1 - Un procedimiento para preparar un derivado de indol - Google Patents

Un procedimiento para preparar un derivado de indol

Info

Publication number
AR192734A1
AR192734A1 AR240009A AR24000972A AR192734A1 AR 192734 A1 AR192734 A1 AR 192734A1 AR 240009 A AR240009 A AR 240009A AR 24000972 A AR24000972 A AR 24000972A AR 192734 A1 AR192734 A1 AR 192734A1
Authority
AR
Argentina
Prior art keywords
preparing
procedure
indole derivative
indole
derivative
Prior art date
Application number
AR240009A
Other languages
English (en)
Spanish (es)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of AR192734A1 publication Critical patent/AR192734A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AR240009A 1971-01-11 1972-01-10 Un procedimiento para preparar un derivado de indol AR192734A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (1)

Publication Number Publication Date
AR192734A1 true AR192734A1 (es) 1973-03-14

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
AR240009A AR192734A1 (es) 1971-01-11 1972-01-10 Un procedimiento para preparar un derivado de indol

Country Status (20)

Country Link
JP (1) JPS5531156B2 (fr)
AR (1) AR192734A1 (fr)
AT (1) AT312595B (fr)
AU (1) AU464388B2 (fr)
BE (1) BE777911A (fr)
CA (1) CA1012150A (fr)
CH (1) CH573938A5 (fr)
CY (1) CY926A (fr)
DK (1) DK150143C (fr)
EG (1) EG10888A (fr)
ES (2) ES398678A1 (fr)
FI (1) FI54120C (fr)
FR (1) FR2121699B1 (fr)
GB (1) GB1366133A (fr)
HK (1) HK52877A (fr)
IE (1) IE35956B1 (fr)
KE (1) KE2777A (fr)
MY (1) MY7800048A (fr)
NL (1) NL174251C (fr)
SE (1) SE398645B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476740A (en) 1974-11-20 1977-06-16 Wyeth John & Brother Ltd Pyrimido-1,2-b-isoquinoline derivatives their preparation and their pharmaceutical compositions
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (ja) * 1977-06-06 1983-10-12 株式会社日立製作所 情報検索装置
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (ja) * 1984-03-28 1985-10-15 Casio Comput Co Ltd デ−タ記憶機能付小型電子機器
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (fr) * 2008-12-15 2010-08-12 Wyeth Llc Agonistes de cb2 de type oxindole substitué

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
FR2121699B1 (fr) 1975-08-01
IE35956L (en) 1972-07-11
GB1366133A (en) 1974-09-11
CA1012150A (en) 1977-06-14
KE2777A (en) 1977-10-21
DK150143B (da) 1986-12-15
CH573938A5 (fr) 1976-03-31
AU3755872A (en) 1973-07-05
NL7200415A (fr) 1972-07-13
JPS5531156B2 (fr) 1980-08-15
DK150143C (da) 1987-06-01
ES398678A1 (es) 1975-05-16
NL174251C (nl) 1984-05-16
BE777911A (fr) 1972-07-11
IE35956B1 (en) 1976-07-07
HK52877A (en) 1977-10-20
FI54120C (fi) 1978-10-10
NL174251B (nl) 1983-12-16
SE398645B (sv) 1978-01-09
CY926A (en) 1977-12-23
ES409296A1 (es) 1976-03-16
AU464388B2 (en) 1975-08-28
EG10888A (en) 1978-06-30
JPS4839500A (fr) 1973-06-09
FI54120B (fi) 1978-06-30
FR2121699A1 (fr) 1972-08-25
AT312595B (de) 1974-01-10
MY7800048A (en) 1978-12-31

Similar Documents

Publication Publication Date Title
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
NO139124C (no) Fremgangsmaate for fremstilling av estere
AR200387A1 (es) Procedimiento para preparar derivados de trifluorometilfenilpiperazina
SE417711B (sv) Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat
AR216885A1 (es) Procedimiento para preparar aminonicotinonitrilos
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
AR194129A1 (es) Un procedimiento para preparar un compuesto de tetrahidrocarbazol
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
NL7507090A (nl) Hexahydro-diazepino-indoolderivaten alsmede werk- wijze ter bereiding daarvan.
SE415974B (sv) Forfarande for framstellning av 2-bensoyl-3-amino-pyridinderivat
AR193281A1 (es) Un procedimiento para preparar los di-n-oxidos de quinoxalina
YU298171A (en) Process for preparing indole derivatives
SE7605364L (sv) Forfarande for framstellning av antracenderivat
SE393983B (sv) Forfarande for framstellning av 2-amino- alkyltio- 3h-1,5-bensodiazepiner
AR207742A1 (es) Procedimiento para preparar(3-fosfonotioureido)ureidobencenos
AR199605A1 (es) Procedimiento para preparar dihidro-2aminoisoquinolinas
BG19187A3 (bg) Метод за изолиране индолови алкалоиди
SE415098B (sv) Forfarande for framstellning av bensotiazoler
GB1405800A (en) Indole derivatives
AR201002A1 (es) Procedimiento para preparar isotiocianobenzoxazoles
AR193213A1 (es) Un procedimiento para preparar derivados benzodiacepinicos
AR193220A1 (es) Un procedimiento para preparar derivados benzodiacepinicos
AR195270A1 (es) Un procedimiento para preparar derivados benzodiacepinicos